Kentaro Fujiwara

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Characteristics and environmental susceptibility of first-pass meconium microbiota in neonates with congenital intestinal atresia.

Characteristics and environmental susceptibility of first-pass meconium microbiota in neonates with congenital intestinal atresia.

Journal: Journal of pediatric surgery

Published: March 17, 2026

Surgical paradox: Physiological activation and improved mood state during surgical work in pediatric surgeons.

Surgical paradox: Physiological activation and improved mood state during surgical work in pediatric surgeons.

Journal: Journal of occupational health

Published: February 23, 2026

12-HHT is associated with epithelial barrier enhancement and reduced inflammatory responses in colon organoids of normoganglionosis in Hirschsprung's disease.

12-HHT is associated with epithelial barrier enhancement and reduced inflammatory responses in colon organoids of normoganglionosis in Hirschsprung's disease.

Journal: PloS one

Published: February 20, 2026

Impact of Epithelial Claudin-4 and Leukotriene B4 Receptor 2 in Normoganglionic Hirschsprung Disease Colon on Post Pull-through Enterocolitis.

Impact of Epithelial Claudin-4 and Leukotriene B4 Receptor 2 in Normoganglionic Hirschsprung Disease Colon on Post Pull-through Enterocolitis.

Journal: Journal of pediatric surgery

Published: August 29, 2024

Evaluating perioperative stresses in children by noninvasive modalities using salivary cortisol and autonomic reactivity.

Evaluating perioperative stresses in children by noninvasive modalities using salivary cortisol and autonomic reactivity.

Journal: Pediatric surgery international

Published: August 02, 2024

A feedback amplifier circuit with Notch and E2A orchestrates T-cell fate and suppresses the innate lymphoid cell lineages during thymic ontogeny.

A feedback amplifier circuit with Notch and E2A orchestrates T-cell fate and suppresses the innate lymphoid cell lineages during thymic ontogeny.

Journal: Genes & development

Published: July 17, 2024

The Current Achievements of Multi-Gene Panel Tests in Clinical Settings for Patients with Non-Small-Cell Lung Cancer.

The Current Achievements of Multi-Gene Panel Tests in Clinical Settings for Patients with Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: March 30, 2024

Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer.

Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer.

Journal: JAMA oncology

Published: March 28, 2024

The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice.

The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice.

Journal: Nuclear medicine communications

Published: September 20, 2023

Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma.

Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma.

Journal: Anticancer research

Published: August 10, 2023

Disruption of a licorice cellulose synthase-derived glycosyltransferase gene demonstrates its in planta role in soyasaponin biosynthesis.

Disruption of a licorice cellulose synthase-derived glycosyltransferase gene demonstrates its in planta role in soyasaponin biosynthesis.

Journal: Plant cell reports

Published: July 30, 2023

Refractory response to entrectinib for ROS-1 rearranged NSCLC with concurrent de novo TP53 mutation showing good response to CNS lesion, but poor duration of response: A case report.

Refractory response to entrectinib for ROS-1 rearranged NSCLC with concurrent de novo TP53 mutation showing good response to CNS lesion, but poor duration of response: A case report.

Journal: Thoracic cancer

Published: June 16, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026